Investment/Collaboration Opportunities

 

EUDENDRON is offering two investment/collaborations opportunities:

 

A) Cancer Targeted Therapies: to develop the novel EUD-GK-91 compound up to proof of concept in animal model

 

B) Kinase Inhibitors Platform: to transfer the successful molecular design applied in the development of EUD-GK-91 to different chemotypes to target the kinome